Key data includes ASCO oral presentation of data from the Rylaze® (asparaginase erwinia chrysanthemi (recombinant)-rywn) Phase 2/3 trial in Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma...

AbbVie will present 46 abstracts for six investigational and approved medicines across eight cancer types A five-year update from the CLL14 Phase 3 VENCLYXTO®/VENCLEXTA® (venetoclax) and...

Since the Mitsubishi Outlander PHEV (plug-in hybrid electric vehicle) launched in 2017 as a 2018 model, the vehicle has reinforced its credentials as the best-selling PHEV sport-utility vehicle in...

Karyopharm Therapeutics Inc. (NASDAQ: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that initial data from a Phase 1 portion of the Ph 1/2...

Arctech, the world's leading tracking, racking, and BIPV solutions provider, announced it has attended the Intersolar 2022 in Munich (Germany) from May 11th to 13th with the latest effort to...